{
    "SPADE_N_14059": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14059",
            "Peptide Name": "Humidimycin (natural AMPs; lactam; a class 1 lasso peptide, 2S=S; XXJ; UCSB1a; bacteriocins; Gram-positive bacteria, prokaryotes)",
            "Source": "isolated fromStreptomyces humidusCA-100629",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "CLGIGSCDDFAGCGYAIVCFW",
            "Sequence Length": 21,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antifungal",
                "Synergistic AMPs"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2200.53,
            "PI": 4.05,
            "Hydrophobicity": 1.17,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Valiante V, Monteiro MC, Martín J, Altwasser R, El Aouad N, González I, Kniemeyer O, Mellado E, Palomo S, de Pedro N, Pérez-Victoria I, Tormo JR, Vicente F, Reyes F, Genilloud O, Brakhage AA. 2015",
                    "Reference": "Antimicrob Agents Chemother. 2015 Sep;59(9):5145-53. doi: 10.1128/AAC.00683-15.PubMed",
                    "Title": "Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010)."
                }
            ],
            "Frequent Amino Acids": "CGA",
            "Absent Amino Acids": "EHKMNOPQRTU",
            "Basic Residues": 0,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 10,
            "Polar Residues": 9,
            "Positive Residues": 0,
            "Negative Residues": 2,
            "Net Charge": -2,
            "Comments": "Discovery: identified from the screening of a collection of 20,000 microbial extracts.Sequence analysis: APD analysis reveals that this sequence is similar (95.24%) toSiamycin IIC=G: 19%; I=F=A=D: 10%. GRAVY:  1.17; mol Wt: 2200.573; mol formula: C98H139N22O28S4; mol ex coeff: 7290.Chemical modification:  cyclized from the side chain of Asp9 to the N-terminus of Cysl. Two disulfide bonds: C1-C13 and C7-C19, lleading to a tricyclic structure. Last W is a D-amino acid (Sánchez-Hidalgo et al., 2020).Activity: inhibits the growth of A. fumigatus and C. albicans in the presence of caspofungin (CAS).Synergy:drug: Potentiated the CAS antifungal effect against A. fumigatus with a decrease in the CAS MEC from 0.12 to 0.015 ug/ml and against C. albicans with a drop in the CAS MIC from 0.25 to 0.03 ug/ml.Recombinant production:bacteria:Escherichia coli: the gene cluster has been cloned into the bacterium and succeeded in peptide expression. Est.Jan2024;",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15067",
                    "Similarity": 0.9523809523809523,
                    "Sequence": "CLGIGSCNDFAGCGYAIVCFW"
                },
                {
                    "SPADE_ID": "SPADE_UN_11376",
                    "Similarity": 0.9523809523809523,
                    "Sequence": "CLGIGSCNDFAGCGYAIVCFW"
                },
                {
                    "SPADE_ID": "SPADE_N_05603",
                    "Similarity": 0.9047619047619048,
                    "Sequence": "CLGVGSCNDFAGCGYAIVCFW"
                }
            ]
        }
    }
}